期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Pulmonary Circulation LetPub Score 5.1
50 ratings
Rate
Reputation 5.8 Influence 3.8 Speed 9.1 | ||||||||||||||||
期刊簡稱 | PULM CIRC | ||||||||||||||||
ISSN | 2045-8932 | ||||||||||||||||
E-ISSN | 2045-8940 | ||||||||||||||||
h-index | 32 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 9.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://journals.sagepub.com/home/pul | ||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/pulmonarycirculation | ||||||||||||||||
開放訪問 | Yes | ||||||||||||||||
出版商 | SAGE Publications Inc. | ||||||||||||||||
主題領域 | Medicine | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 134每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 75.25% | ||||||||||||||||
OA Related Info | APC: Yes( USD2310; GBP1730; EUR1940; ) APC waiver:Check Notes Other charges: No Keywords: pulmonary circulation、hypertension、vascular disease、cardiopulmonary disease Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2045-8932%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 15 Weeks | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Pulmonary Circulation] 的評論 | 撰寫評論 |
作者: 风芹小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-02 11:42:07 評論於 Research focus: Pulmonary arterial hypertension; Experience sharing on pulmonary hypertension: One meta-analysis, already revised three times majorly and once minorly, currently awaiting final decision for a week. Previously, one reviewer was unfriendly and the journal has been delaying the final decision, giving a bad feeling. Hopefully, it won't be dragged on for too long. If they don't want it, it's better to reject it early.(0) 讚! | 风芹小哥哥 |
作者: 风芹小哥哥 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-02 09:53:18 評論於 The representative is currently selecting reviewers, and the next step will be awaiting reviewer invitation.(0) 讚! | 风芹小哥哥 |
作者: 葵花锦华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-23 21:44:08 評論於 What does "awaiting review selection" mean? Does it mean it hasn't been submitted for review yet?(0) 讚! | 葵花锦华 |
作者: 葵花锦华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-21 23:55:09 評論於 How long has it been going on?(0) 讚! | 葵花锦华 |
作者: 葵花锦华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-21 18:39:33 評論於 How long has it been going on?(0) 讚! | 葵花锦华 |
作者: 葵花锦华 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-07 09:06:50 評論於 Have you accepted?(0) 讚! | 葵花锦华 |
作者: 魂魄瑞霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-09 23:18:22 評論於 Review speed: 12.0 | Submission hit rate: 75.0 Emphasis on research direction: PE Experience sharing: Submitted in May, accepted today, accepted after two major revisions, editor is very good(0) 讚! | 魂魄瑞霞 |
作者: 易筋初风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-21 21:50:56 評論於 How long does it take to await reviewer selection? It has been 2 weeks since submission and it is still in this state(0) 讚! | 易筋初风 |
作者: 东风谷雪磊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-02 19:38:14 評論於 Have you submitted your manuscript for review? How long does the first review usually take?(0) 讚! | 东风谷雪磊 |
作者: 八卦世昌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-05 16:31:53 評論於 Please translate the following passage into English and Japanese, with titles ":" and ":": 3.017(0) 讚! | 八卦世昌 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:23:55 評論於 The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific limit on the number of words in this section. Different articles and authors have varying lengths for the discussion section, with some being a few thousand words and others being tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 11:36:47 評論於 Is the extensive discussion showing the author's reflection on the topic? Are the reviewers impressed by the manuscript?(0) 讚! | 魂魄彦露 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:33:18 評論於 What is IF?(0) 讚! | 陶宜三岁啦 |
作者: Elroy Houston 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-17 13:26:12 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Main research direction: Pulmonary arterial hypertension Experience sharing: Successfully published a paper in 2020, recently received a notification of acceptance for another paper, but the publisher has changed, please let me know if you are aware of this(0) 讚! | Elroy Houston |
作者: 八卦世昌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-13 22:37:31 評論於 How long does the review process take?(0) 讚! | 八卦世昌 |
作者: 晨风盼菡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-27 11:16:32 評論於 Review speed: 2.0 | Acceptance rate: 50.0 Experience sharing: This is a journal that I feel very good about. I submitted a meta related to pulmonary vascular diseases, underwent major revision once and minor revision once, and then it was accepted. However, there is an APC fee(0) 讚! | 晨风盼菡 |
作者: bba 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-08-22 16:39:27 評論於 There are a lot of good cardiovascular journals, and this is a very common journal. If you want to select a journal based on a high score, consider this one. (0) 讚! | bba |
作者: 云来初文 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-22 10:41:33 評論於 There are many good journals on cardiovascular, this one can only be considered as a very ordinary journal. If you want to publish high-quality papers, consider switching to a different one(0) 讚! | 云来初文 |
作者: 南川柔绚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-21 09:58:02 評論於 I just want to add an IF(0) 讚! | 南川柔绚 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us